List was last updated on
.-
- The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in BRCA Mutation Carriers and the Role of Physician-Patient Communication.
- Alves-Nogueira AC, Melo D, Carona C, Figueiredo-Dias M.
- Curr Oncol. 2023 Feb 18;30(2):2429-2440. doi: 10.3390/curroncol30020185.
-
- Counselling of path_BRCA carriers who are considering risk-reducing oophorectomy.
- Manley K, Ryan N, Jenner A, Newton C, Hillard T.
- Post Reprod Health. 2023 Feb 9:20533691231156640. doi: 10.1177/20533691231156640. Epub ahead of print.
- PMID: 36757900
- PubMed abstract
- Source abstract
-
- Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic.
- Zimovjanova M, Bielcikova Z, Miskovicova M, Vocka M, Zimovjanova A, Marian Rybar M, Novotny J, Petruzelka L.
- Cancers (Basel). 2023 Feb 8;15(4):1072. doi: 10.3390/cancers15041072.
-
- Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review.
- Nitschke AS, Abreu do Valle H, Dawson L, Kwon JS, Hanley GE.
- Cancers (Basel). 2023 Jan 24;15(3):711. doi: 10.3390/cancers15030711.
- Review
- Free Full Text
-
- Hormone replacement therapy in BRCA mutation carriers: how shall we do no harm?
- Loizzi V, Dellino M, Cerbone M, Arezzo F, Chiariello G, Lepera A, Cazzato G, Cascardi E, Damiani GR, Cicinelli E, Cormio G.
- Hormones (Athens). 2023 Jan 13. doi: 10.1007/s42000-022-00427-1. Epub ahead of print.
- PMID: 36637775
- PubMed abstract
- Source abstract
-
- Use of exogenous hormones in those at increased risk for breast cancer: contraceptive and menopausal hormones in gene carriers and other high-risk patients.
- Pederson HJ, Batur P.
- Menopause. 2023 Jan 10. doi: 10.1097/GME.0000000000002136. Epub ahead of print.
- PMID: 36626703
- PubMed abstract
- Source abstract
- Review
-
- The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows.
- Loizzi V, Dellino M, Cerbone M, Arezzo F, Cazzato G, Damiani GR, Pinto V, Silvestris E, Kardhashi A, Cicinelli E, Cascardi E, Cormio G.
- Int J Mol Sci. 2023 Jan 1;24(1):764. doi: 10.3390/ijms24010764.
- Review
- Free Full Text
-
- Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.
- Matan LS, Perri T, Kogan L, Brandt B, Meyer R, Levin G.
- Eur J Obstet Gynecol Reprod Biol. 2022 Nov;278:166-171. doi: 10.1016/j.ejogrb.2022.09.035. Epub 2022 Sep 29.
- PMID: 36208522
- PubMed abstract
- Source abstract
-
- Trajectories of metabolic parameters after bilateral oophorectomy in premenopausal women.
- Kapoor E, Faubion SS, Gazzuola Rocca L, Mielke MM, Smith CY, Rocca WA.
- Maturitas. 2022 Nov;165:38-46. doi: 10.1016/j.maturitas.2022.07.005. Epub 2022 Jul 21.
- PMID: 35905571
- PubMed abstract
-
- What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomy.
- Moss KM, Mishra GD, Krejany EO, Hickey M.
- Gynecol Oncol. 2022 Oct;167(1):58-64. doi: 10.1016/j.ygyno.2022.07.029. Epub 2022 Aug 4.
- PMID: 35933227
- PubMed abstract
-
- Surgical Menopause and Bilateral Oophorectomy: Effect of Estrogen-Progesterone and Testosterone Replacement Therapy on Psychological Well-being and Sexual Functioning; A Systematic Literature Review.
- Stuursma A, Lanjouw L, Idema DL, de Bock GH, Mourits MJE.
- J Sex Med. 2022 Sep 26:S1743-6095(22)01769-6. doi: 10.1016/j.jsxm.2022.08.191. Epub ahead of print.
- PMID: 36175351
- PubMed abstract
- Review
- Free Full Text
Review registration number: CRD42019136698: The effect of hormone replacement therapy on psychological well-being and sexual functioning in women after treatment-induced menopause. (PROSPERO register)
-
- Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2.
- Bernstein-Molho R, Friedman E, Evron E.
- Cancers (Basel). 2022 Sep 22;14(19):4592. doi: 10.3390/cancers14194592.
- PMID: 36230512
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Scene memory and hippocampal volume in middle-aged women with early hormone loss.
- Gervais NJ, Gravelsins L, Brown A, Reuben R, Karkaby L, Baker-Sullivan E, Mendoza L, Lauzon C, Almey A, Foulkes WD, Bernardini MQ, Jacobson M, Velsher L, Rajah MN, Olsen RK, Grady C, Einstein G.
- Neurobiol Aging. 2022 Sep;117:97-106. doi: 10.1016/j.neurobiolaging.2022.05.003. Epub 2022 May 13.
- PMID: 35696793
- PubMed abstract
- Source abstract
-
- Incidence of pelvic high-grade serous carcinoma after isolated STIC diagnosis: A systematic review of the literature.
- Linz VC, Löwe A, van der Ven J, Hasenburg A, Battista MJ.
- Front Oncol. 2022 Aug 31;12:951292. doi: 10.3389/fonc.2022.951292.
- PMID: 36119503
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants.
- Edaily S, Abdel-Razeq H.
- Onco Targets Ther. 2022 Jul 27;15:815-826. doi: 10.2147/OTT.S369844.
- PMID: 35923470
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Study: Risk-reducing ovarian cancer surgery and quality of life.
- [No author given]
- FORCE. XRAY. 2022 Jul 26.
- Research news
- Free Full Text
Original research:
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.
- PMID: 34081085
- PubMed abstract
- Free Full Text
-
- Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
- Mai PL, Miller A, Black A, Falk RT, Boggess JF, Tucker K, Stuckey AR, Rodriguez GC, Wong C, Amatruda TT, Wilkinson KJ, Modesitt SC, Yamada SD, Bixel KL, Glaser GE, Rose PG, Greene MH, Sherman ME.
- Am J Obstet Gynecol. 2022 Jul;227(1):61.e1-61.e18. doi: 10.1016/j.ajog.2022.02.022. Epub 2022 Feb 22.
- PMID: 35216968
- PubMed abstract
- Source abstract
-
- Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.
- do Valle HA, Kaur P, Kwon JS, Cheifetz R, Dawson L, Hanley GE.
- J Gynecol Oncol. 2022 Jul;33(4):e51. doi: 10.3802/jgo.2022.33.e51. Epub 2022 Mar 30.
- PMID: 35557034
- PubMed abstract
- Source abstract
-
- Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomy.
- van Winden LJ, Vermeulen RFM, van den Noort V, Gaarenstroom KN, Kenter GG, Brood-van Zanten MMA, Korse CM, van Beurden M, van Rossum HH.
- J Endocr Soc. 2022 Apr 25 [eCollection 2022 Jun];6(6):bvac069. doi: 10.1210/jendso/bvac069.
- PMID: 35592509
- PubMed abstract
-
- Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.
- Schrijver LH, Mooij TM, Pijpe A, Sonke GS, Mourits MJE, Andrieu N, Antoniou AC, Easton DF, Engel C, Goldgar D, John EM, Kast K, Milne RL, Olsson H, Phillips KA, Terry MB, Hopper JL, van Leeuwen FE, Rookus MA.
- J Natl Cancer Inst. 2022 Apr 11;114(4):540-552. doi: 10.1093/jnci/djac004.
- PMID: 35048954
- PubMed abstract
Commentary:
Oral Contraceptives and BRCA Cancer: A Balancing Act.
- PMID: 35048983
- PubMed abstract
- Free Full Text
-
- Major clinical research advances in gynecologic cancer in 2021.
- Park JY, Lee JY, Lee YY, Shim SH, Suh DH, Kim JW.
- J Gynecol Oncol. 2022 Mar;33(2):e43. doi: 10.3802/jgo.2022.33.e43.
- PMID: 35245004
- PubMed abstract
- Source abstract
- Review, Conference report
- Free Full Text
-
- Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2.
- Samuel D, Diaz-Barbe A, Pinto A, Schlumbrecht M, George S.
- Cells. 2022 Feb 4;11(3):539. doi: 10.3390/cells11030539.
- PMID: 35159349
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66.
- Manchanda R, Gaba F, Talaulikar V, Pundir J, Gessler S, Davies M, Menon U; Royal College of Obstetricians and Gynaecologists.
- BJOG. 2022 Jan;129(1):e16-e34. doi: 10.1111/1471-0528.16896. Epub 2021 Oct 20.
- PMID: 34672090
- PubMed abstract
- Source abstract
- Guideline
- Free Full Text
-
- Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic.
- Jacobson MR, Walker M, Ene GEV, Firestone C, Bernardini MQ, Allen L, Huszti E, Sobel M.
- Menopause. 2021 Dec 6;29(2):151-155. doi: 10.1097/GME.0000000000001900.
- PMID: 34873108
- PubMed abstract
- Source abstract
Video: Video Summary (Menopause)
-
- Menopausal hormone therapy and breast cancer risk.
- Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C.
- Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101577. doi: 10.1016/j.beem.2021.101577. Epub 2021 Sep 10.
- PMID: 34535397
- PubMed abstract
- Source abstract
-
- Guideline No. 422f: Menopause and Breast Cancer.
- Jacobson M, Mills K, Graves G, Wolfman W, Fortier M.
- J Obstet Gynaecol Can. 2021 Dec;43(12):1450-1456.e1. doi: 10.1016/j.jogc.2021.09.011. Epub 2021 Nov 17.
- PMID: 34895583
- PubMed abstract
- Source abstract
-
- Association of Premenopausal Bilateral Oophorectomy With Cognitive Performance and Risk of Mild Cognitive Impairment.
- Rocca WA, Lohse CM, Smith CY, Fields JA, Machulda MM, Mielke MM.
- JAMA Netw Open. 2021 Nov 1;4(11):e2131448. doi: 10.1001/jamanetworkopen.2021.31448.
- PMID: 34762113
- PubMed abstract
Commentary:
Long-term Risk of Cognitive Impairment and Dementia Following Bilateral Oophorectomy in Premenopausal Women-Time to Rethink Policies?
- PMID: 34762116
- PubMed abstract
- Free Full Text
-
- Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
- Saccardi C, Zovato S, Spagnol G, Bonaldo G, Marchetti M, Alessandrini L, Tognazzo S, Guerriero A, Vitagliano A, Laganà AS, Noventa M.
- Gynecol Oncol. 2021 Nov;163(2):364-370. doi: 10.1016/j.ygyno.2021.08.021. Epub 2021 Aug 28.
- PMID: 34465478
- PubMed abstract
- Source abstract
-
- Study Seeks to Prevent Cancer and Extend Quality of Life for Women at Increased Genetic Risk of Ovarian Cancer.
- Jenks S.
- FORCE. Blog. 2021 Oct 12.
- Blog post
- Free Full Text
-
- What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomy.
- Hickey M, Moss KM, Krejany EO, Wrede CD, Brand A, Kirk J, Symecko HL, Domchek SM, Tejada-Berges T, Trainer A, Mishra GD.
- Gynecol Oncol. 2021 Oct;163(1):148-154. doi: 10.1016/j.ygyno.2021.07.029. Epub 2021 Jul 24.
- PMID: 34312002
- PubMed abstract
- Source abstract
-
- Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline.
- Jacobson M, Coakley N, Bernardini M, Branco KA, Elit L, Ferguson S, Kim R.
- Hered Cancer Clin Pract. 2021 Sep 26;19(1):39. doi: 10.1186/s13053-021-00196-9.
- PMID: 34565426
- PubMed abstract
- Review. Guideline.
- Free PMC article
- Free Full Text
-
- Risk of cardiovascular disease among women carrying BRCA mutations after risk-reducing bilateral salpingo-oophorectomy: A population-based study.
- do Valle HA, Kaur P, Kwon JS, Cheifetz R, Dawson L, Hanley GE.
- Gynecol Oncol. 2021 Sep;162(3):707-714. doi: 10.1016/j.ygyno.2021.06.022. Epub 2021 Jul 1.
- PMID: 34217543
- PubMed abstract
- Source abstract
-
- The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
- Kershaw V, Hickey I, Wyld L, Jha S.
- Eur J Obstet Gynecol Reprod Biol. 2021 Aug 8;265:7-17. doi: 10.1016/j.ejogrb.2021.08.001. Epub ahead of print.
- PMID: 34416580
- PubMed abstract
- Source abstract
-
- Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.
- Steenbeek MP, Harmsen MG, Hoogerbrugge N, de Jong MA, Maas AHEM, Prins JB, Bulten J, Teerenstra S, van Bommel MHD, van Doorn HC, Mourits MJE, van Beurden M, Zweemer RP, Gaarenstroom KN, Slangen BFM, Brood-van Zanten MMA, Vos MC, Piek JMJ, van Lonkhuijzen LRCW, Apperloo MJA, Coppus SFPJ, Massuger LFAG, IntHout J, Hermens RPMG, de Hullu JA.
- JAMA Oncol. 2021 Aug 1;7(8):1203-1212. doi: 10.1001/jamaoncol.2021.1590.
- PMID: 34081085
- PubMed abstract
Identifier: NCT02321228: Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers (TUBA). (ClinicalTrials.gov)
Research news: Study: Risk-reducing ovarian cancer surgery and quality of life. (FORCE. XRAY.)
-
- What happens after menopause? (WHAM): A prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomy.
- Hickey M, Moss KM, Krejany EO, Wrede CD, Domchek SM, Kirk J, Brand A, Trainer A, Mishra GD, Baker FC.
- Gynecol Oncol. 2021 Aug;162(2):447-453. doi: 10.1016/j.ygyno.2021.05.036. Epub 2021 Jun 8.
- PMID: 34116835
- PubMed abstract
- Source abstract
-
- Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers - an Israeli matched pair study.
- Perri T, Levin G, Naor-Revel S, Eliassi-Revivo P, Lifshitz D, Friedman E, Korach J.
- Int J Gynaecol Obstet. 2021 Jul 29. doi: 10.1002/ijgo.13843. Epub ahead of print.
- PMID: 34324701
- PubMed abstract
- Source abstract
-
- BRCA, breast cancer and in vitro fertilization: How should we advise our patients?
- García-Planells J, Francés BS, Diez-Juan A.
- Fertil Steril. 2021 Jul 8:S0015-0282(21)00505-7. doi: 10.1016/j.fertnstert.2021.06.011. Epub ahead of print.
- PMID: 34247761
- PubMed abstract
- Commentary
- Free Full Text
Original research:
Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers.
- PMID: 33823990
- PubMed abstract
- Source abstract
-
- What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
- Hickey M, Moss KM, Mishra GD, Krejany EO, Domchek SM, Wark JD, Trainer A, Wild RA.
- Gynecol Oncol. 2021 Jul;162(1):88-96. doi: 10.1016/j.ygyno.2021.04.038. Epub 2021 May 7.
- PMID: 33972087
- PubMed abstract
- Source abstract
-
- An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
- Kotsopoulos J, Kim SJ, Armel S, Bordeleau L, Foulkes WD, McKinnon W, Panchal S, Cohen SA, Sun S, Sun P, McKetton L, Troyer AK, Narod SA.
- Cancer. 2021 Jun 2. doi: 10.1002/cncr.33654. Epub ahead of print.
- PMID: 34077552
- PubMed abstract
- Source abstract
-
- Hormone Replacement Therapy After Gynaecological Malignancies: a Review Article.
- Sourouni M, Kiesel L.
- Geburtshilfe Frauenheilkd. 2021 May;81(5):549-554. doi: 10.1055/a-1390-4353. Epub 2021 May 20.
- PMID: 34035549
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
- Hickey M, Moss KM, Brand A, Wrede CD, Domchek SM, Meiser B, Mishra GD, Joffe H.
- Gynecol Oncol. 2021 May;161(2):527-534. doi: 10.1016/j.ygyno.2021.02.001. Epub 2021 Feb 11.
- PMID: 33583580
- PubMed abstract
- Source abstract
-
- Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review.
- Huber D, Seitz S, Kast K, Emons G, Ortmann O.
- J Cancer Res Clin Oncol. 2021 Apr 22. doi: 10.1007/s00432-021-03629-z. Epub ahead of print.
- PMID: 33885953
- PubMed abstract
- Review
- Free Full Text
-
- Management of patients with BRCA mutation from the point of view of a breast surgeon.
- Riis ML.
- Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311.
- PMID: 33996049
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Controversies in Hereditary Cancer Management.
- AlHilli MM, Pederson HJ.
- Obstet Gynecol. 2021 Apr 8. doi: 10.1097/AOG.0000000000004364. Epub ahead of print.
- PMID: 33831930
- PubMed abstract
- Source abstract
-
- The management of menopausal symptoms in women following treatment for cancer at a specialist menopause service.
- Chakrabarti R, Holloway D, Bruce D, Rymer J.
- Post Reprod Health. 2021 Apr 7:20533691211000548. doi: 10.1177/20533691211000548. Epub ahead of print.
- PMID: 33823682
- PubMed abstract
- Source abstract
-
- Why So Many of Us Quit Taking Tamoxifen.
- Horner K.
- FORCE. Blog. 2021 Apr 6.
- Blog post
- Free Full Text
Research news: Study: How breast cancer patients experience hormone therapy (FORCE. XRAY.)
-
- Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.
- Michaelson-Cohen R, Gabizon-Peretz S, Armon S, Srebnik-Moshe N, Mor P, Tomer A, Levy-Lahad E, Paluch-Shimon S.
- Eur J Cancer. 2021 Mar 16;148:95-102. doi: 10.1016/j.ejca.2021.02.007. Epub ahead of print.
- PMID: 33743487
- PubMed abstract
- Source abstract
-
- A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
- Islam RM, Davis SR, Bell RJ, Tejada-Berges T, Wrede CD, Domchek SM, Meiser B, Kirk J, Krejany EO, Hickey M.
- Menopause. 2021 Mar 15;28(7):748-755. doi: 10.1097/GME.0000000000001766.
- PMID: 33739311
- PubMed abstract
- Source abstract
-
- Management of menopausal symptoms and ovarian function preservation in women with gynecological cancer.
- Brennan A, Brennan D, Rees M, Hickey M.
- Int J Gynecol Cancer. 2021 Mar;31(3):352-359. doi: 10.1136/ijgc-2020-002032. Epub 2020 Oct 30.
- PMID: 33127864
- PubMed abstract
- Source abstract
-
- Association of Premenopausal Bilateral Oophorectomy With Restless Legs Syndrome.
- Huo N, Smith CY, Gazzuola Rocca L, Rocca WA, Mielke MM.
- JAMA Netw Open. 2021 Feb 1;4(2):e2036058. doi: 10.1001/jamanetworkopen.2020.36058.
- PMID: 33523190
- PubMed abstract
-
- Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.
- Grandi G, Sammarini M, Cortesi L, Toss A, Botticelli L, Varliero F, Sighinolfi G, Barbieri E, Facchinetti F.
- Menopause. 2021 Feb 1. doi: 10.1097/GME.0000000000001737. Epub ahead of print.
- PMID: 33534430
- PubMed abstract
- Source abstract
-
- Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study).
- Terra L, Hooning MJ, Heemskerk-Gerritsen BAM, van Beurden M, Roeters van Lennep JE, van Doorn HC, de Hullu JA, Mom C, van Dorst EBL, Mourits MJE, Slangen BFM, Gaarenstroom KN, Zillikens MC, Leiner T, van der Kolk L, Collee M, Wevers M, Ausems MGEM, van Engelen K, Berger LP, van Asperen CJ, Gomez-Garcia EB, van de Beek I, Rookus MA, Hauptmann M, Bleiker EM, Schagen SB, Aaronson NK, Maas AHEM, van Leeuwen FE.
- JMIR Res Protoc. 2021 Jan 22;10(1):e24414. doi: 10.2196/24414.
- PMID: 33480862
- PubMed abstract
Study Record Detail: Health After eaRly Menopause Due to Oophorectomy (HARMOny). (ClinicalTrials.gov)
-
- Study: Women support delayed removal of ovaries.
- [No author given]
- FORCE. XRAY. 2020 Dec 24.
- Research news
- Free Full Text
Original research:
Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
- PMID: 32803845
- PubMed abstract
- Free Full Text
-
- The psychosexual effects of risk-reducing bilateral salpingo-oophorectomy in female BRCA1/2 mutation carriers: A systematic review of qualitative studies.
- Hickey I, Jha S, Wyld L.
- Gynecol Oncol. 2020 Dec 11:S0090-8258(20)34164-0. doi: 10.1016/j.ygyno.2020.12.001. Epub ahead of print.
- PMID: 33317909
- PubMed abstract
- Source abstract
-
- Endometrial cancer in germline BRCA mutation carriers: a systematic review and meta-analysis.
- Matanes E, Volodarsky-Perel A, Eisenberg N, Rottenstreich M, Yasmeen A, Mitric C, Lau S, Salvador S, Gotlieb WH, Kogan L.
- J Minim Invasive Gynecol. 2020 Nov 26:S1553-4650(20)31141-9. doi: 10.1016/j.jmig.2020.11.023. Epub ahead of print.
- PMID: 33249269
- PubMed abstract
- Source abstract
-
- No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.
- van Bommel MHD, de Jong MA, Steenbeek MP, Bots ML, van Westerop LLM, Hopman MTE, Hoogerbrugge N, de Hullu JA, Maas AHEM.
- J Cardiol. 2020 Nov 20:S0914-5087(20)30364-6. doi: 10.1016/j.jjcc.2020.11.005. Epub ahead of print.
- PMID: 33229237
- PubMed abstract
-
- Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest.
- Worcester S.
- Medscape. News & Perspective. 2020 Oct 16.
- Research news
- Free Full Text
Original research:
Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
- PMID: 32803845
- PubMed abstract
- Free Full Text
-
- Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.
- Kobayashi Y, Hirasawa A, Chiyoda T, Ueki A, Masuda K, Misu K, Kawaida M, Hayashi S, Kataoka F, Banno K, Kosaki K, Aoki D.
- Jpn J Clin Oncol. 2020 Oct 10:hyaa173. doi: 10.1093/jjco/hyaa173. Epub ahead of print.
- PMID: 33037428
- PubMed abstract
- Source abstract
-
- Patient reported experiences following laparoscopic prophylactic bilateral salpingo-oophorectomy or salpingectomy in an ambulatory care hospital.
- Trister R, Jacobson M, Nguyen P, Sobel M, Allen L, Narod SA, Kotsopoulos J.
- Fam Cancer. 2020 Sep 23. doi: 10.1007/s10689-020-00208-y. Epub ahead of print.
- PMID: 32964297
- PubMed abstract
- Source abstract
-
- Cardiovascular Prevention in Individuals at High Risk of Developing Cancer.
- Oren O, Kopecky SL, Blumenthal RS, Gersh BJ, Yang EH.
- JACC CardioOncol. 2020 Sep 15;2(3):527-531. doi: 10.1016/j.jaccao.2020.07.002.
- PMID: 34396264
- PubMed abstract
- Case report, Review
- Free PMC article
- Free Full Text
-
- Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
- Gaba F, Blyuss O, Chandrasekaran D, Osman M, Goyal S, Gan C, Izatt L, Tripathi V, Esteban I, McNicol L, Ragupathy K, Crawford R, Evans DG, Legood R, Menon U, Manchanda R.
- BJOG. 2020 Aug 16. doi: 10.1111/1471-0528.16424. Epub ahead of print.
- PMID: 32803845
- PubMed abstract
- Source abstract
Commentary:
Attitudes towards risk-reducing salpingectomy: listen to the patients.
- PMID: 32892497
- PubMed abstract
- Source abstract
Press: Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest (Medscape. News & Perspective.)
Research news: Study: Women support delayed removal of ovaries (FORCE. XRAY.)
-
- Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers.
- Mejia-Gomez J, Gronwald J, Senter L, Karlan BY, Tung N, Wolfman W, Demsky R, Sun P, Narod SA, Kotsopoulos J; and the Hereditary Breast Cancer Clinical Study Group.
- Menopause. 2020 Aug 10. doi: 10.1097/GME.0000000000001629. Epub ahead of print.
- PMID: 32796289
- PubMed abstract
- Source abstract
-
- Hormone therapy after risk-reducing surgery in patients with BRCA1/BRCA2 mutation: evaluation of potential benefits and safety.
- Silva Filho ALD, Carvalho GM, Sena LC, Gomes LPG, Valério MFH, Martins RIL, Cândido EB.
- Rev Assoc Med Bras (1992). 2020 Aug;66(8):1134-1138. doi: 10.1590/1806-9282.66.8.1134.
- PMID: 32935810
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database.
- Dominguez-Valentin M, Seppälä TT, Engel C, Aretz S, Macrae F, Winship I, Capella G, Thomas H, Hovig E, Nielsen M, Sijmons RH, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Mints M, Gluck N, Katz L, Heinimann K, Vaccaro CA, Green K, Lalloo F, Hill J, Schmiegel W, Vangala D, Perne C, Strauß HG, Tecklenburg J, Holinski-Feder E, Steinke-Lange V, Mecklin JP, Plazzer JP, Pineda M, Navarro M, Vidal JB, Kariv R, Rosner G, Piñero TA, Gonzalez ML, Kalfayan P, Sampson JR, Ryan NAJ, Evans DG, Møller P, Crosbie EJ.
- J Clin Med. 2020 Jul 18;9(7):2290. doi: 10.3390/jcm9072290.
- PMID: 32708519
- PubMed abstract
- Source abstract
-
- Minilaparoscopic single-site bilateral salpingo-oophorectomy: a scarless prophylactic procedure.
- Casarin J, Laganà AS, Pinelli C, Cromi A, Ghezzi F.
- Minim Invasive Ther Allied Technol. 2020 Jul 16:1-6. doi: 10.1080/13645706.2020.1790391. Epub ahead of print.
- PMID: 32672130
- PubMed abstract
- Source abstract
-
- Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which?
- Grandi G, Caroli M, Cortesi L, Toss A, Tazzioli G, Facchinetti F.
- Expert Opin Drug Saf. 2020 Jul 10:1-6. doi: 10.1080/14740338.2020.1791818. Epub ahead of print.
- PMID: 32648787
- PubMed abstract
- Source abstract
-
- The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, study.
- Grandi G, Del Savio MC, Sammarini M, Cortesi L, Toss A, Piombino C, Facchinetti F.
- Eur J Cancer Prev. 2020 Jun 8. doi: 10.1097/CEJ.0000000000000606. Epub ahead of print.
- PMID: 32516171
- PubMed abstract
- Source abstract
-
- Factors associated with counseling and postoperative hormone therapy use in surgically menopausal women.
- Verrilli L, Brown H, Williams M.
- Menopause. 2020 May 11. doi: 10.1097/GME.0000000000001560. Epub ahead of print.
- PMID: 32404796
- PubMed abstract
- Source abstract
-
- Cognitive markers of dementia risk in middle-aged women with bilateral salpingo-oophorectomy prior to menopause.
- Gervais NJ, Au A, Almey A, Duchesne A, Gravelsins L, Brown A, Reuben R, Baker-Sullivan E, Schwartz DH, Evans K, Bernardini MQ, Eisen A, Meschino WS, Foulkes WD, Hampson E, Einstein G.
- Neurobiol Aging. 2020 Apr 29;94:1-6. doi: 10.1016/j.neurobiolaging.2020.04.019. Epub ahead of print.
- PMID: 32497876
- PubMed abstract
- Source abstract
-
- Hormone Therapy Use After Premature Surgical Menopause Based on Prescription Records: A Population-Based Study.
- Jang JH, Arora N, Kwon JS, Hanley GE.
- J Obstet Gynaecol Can. 2020 Apr 27:S1701-2163(20)30336-4. doi: 10.1016/j.jogc.2020.03.022. Epub ahead of print.
- PMID: 32723606
- PubMed abstract
- Source abstract
-
- Risk of cardiovascular disease after preventive salpingo-oophorectomy.
- Johansen N, Tonstad S, Liavaag AH, Selmer RM, Tanbo TG, Michelsen TM.
- Int J Gynecol Cancer. 2020 Apr 23. pii: ijgc-2019-000856. doi: 10.1136/ijgc-2019-000856. [Epub ahead of print]
- PMID: 32332121
- PubMed abstract
- Source abstract
-
- Executive function after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: does current mood and early life adversity matter?
- Shanmugan S, Sammel MD, Loughead J, Ruparel K, Gur RC, Brown TE, Faust J, Domchek S, Epperson CN.
- Menopause. 2020 Mar 16. doi: 10.1097/GME.0000000000001535. [Epub ahead of print]
- PMID: 32187134
- PubMed abstract
- Source abstract
-
- Hormone Replacement Therapy Prescription After Premature Surgical Menopause.
- Garg N, Behbehani S, Kosiorek H, Wasson M.
- J Minim Invasive Gynecol. 2020 Mar 12. pii: S1553-4650(20)30124-2. doi: 10.1016/j.jmig.2020.03.002. [Epub ahead of print]
- PMID: 32173578
- PubMed abstract
- Source abstract
-
- Clinical Effects of Early or Surgical Menopause.
- Kingsberg SA, Larkin LC, Liu JH.
- Obstet Gynecol. 2020 Mar 10. doi: 10.1097/AOG.0000000000003729. [Epub ahead of print]
- PMID: 32168205
- PubMed abstract
- Source abstract
-
- Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
- Mills KA, Joshi TV, West L, Kuznicki M, Kent L, Hokenstad AN, Cripe JC, Woolfolk C, Senter L, Bakkum-Gamez JN, Wenham RM, Cohn DE, Bae-Jump V, Thaker PH.
- Gynecol Oncol. 2020 Mar 3. pii: S0090-8258(20)30179-7. doi: 10.1016/j.ygyno.2020.02.033. [Epub ahead of print]
- PMID: 32143914
- PubMed abstract
- Source abstract
-
- Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society.
- Sinno AK, Pinkerton J, Febbraro T, Jones N, Khanna N, Temkin S, Iglesias D, Pothuri B.
- Gynecol Oncol. 2020 Feb 14. pii: S0090-8258(20)30088-3. doi: 10.1016/j.ygyno.2020.01.035. [Epub ahead of print]
- PMID: 32067815
- PubMed abstract
- Source abstract
-
- Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers.
- Gaba F, Manchanda R.
- Best Pract Res Clin Obstet Gynaecol. 2020 Feb 4. pii: S1521-6934(20)30018-3. doi: 10.1016/j.bpobgyn.2020.01.006. [Epub ahead of print]
- PMID: 32192936
- PubMed abstract
- Review
- Free Full Text
-
- The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies.
- Kyo S, Ishikawa N, Nakamura K, Nakayama K.
- Cancer Med. 2019 Nov 25. doi: 10.1002/cam4.2725. [Epub ahead of print]
- PMID: 31769234
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.
- Mai PL, Huang HQ, Wenzel LB, Han PK, Moser RP, Rodriguez GC, Boggess J, Rutherford TJ, Cohn DE, Kauff ND, Phillips KA, Wilkinson K, Wenham RM, Hamilton C, Powell MA, Walker JL, Greene MH, Hensley ML.
- Gynecol Oncol. 2019 Nov 21. pii: S0090-8258(19)31613-0. doi: 10.1016/j.ygyno.2019.10.026. [Epub ahead of print]
- PMID: 31759774
- PubMed abstract
- Source abstract
-
- Use of antidepressants in women after prophylactic bilateral oophorectomy: A Danish national cohort study.
- Abildgaard J, Ahlström MG, Nielsen DL, Daugaard G, Lindegaard B, Obel N, Lidegaard Ø.
- Psychooncology. 2019 Nov 16. doi: 10.1002/pon.5290. [Epub ahead of print]
- PMID: 31733110
- PubMed abstract
- Source abstract
-
- Menopausal hormone therapy for BRCA-mutation carriers: attitudes of Israeli healthcare providers before and after a brief educational intervention.
- Perri T, Farhadian Y, Friedman E, Korach J.
- Menopause. 2019 Nov 4. doi: 10.1097/GME.0000000000001432. [Epub ahead of print]
- PMID: 31688415
- PubMed abstract
- Source abstract
-
- Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer.
- [No author given]
- National Institute for Health and Care Excellence (UK): Clinical Guidelines; 2013 Jun. [Last Update: November 2019.]
- PMID: 31940157
- PubMed abstract
- Guidelines
- Free Full Text
-
- Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?
- Kotsopoulos J, Gronwald J, Lubinski J, McCuaig J, Lynch HT, Neuhausen SL, Foulkes WD, Weitzel JN, Senter L, Tung N, Eng C, Karlan B, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.
- Menopause. 2019 Oct 21. doi: 10.1097/GME.0000000000001437. [Epub ahead of print]
- PMID: 31644510
- PubMed abstract
- Source abstract
-
- What information do healthcare professionals need to inform premenopausal women about risk-reducing salpingo-oophorectomy?
- Hickey M, Rio I, Trainer A, Marino JL, Wrede CD, Peate M.
- Menopause. 2019 Sep 16. doi: 10.1097/GME.0000000000001421. [Epub ahead of print]
- PMID: 31567874
- PubMed abstract
- Source abstract
-
- Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation.
- Kotsopoulos J, Hall E, Finch A, Hu H, Murphy J, Rosen B, Narod SA, Cheung AM.
- JAMA Netw Open. 2019 Aug 2;2(8):e198420. doi: 10.1001/jamanetworkopen.2019.8420.
- PMID: 31390031
- PubMed abstract
-
- Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
- Gasparri ML, Taghavi K, Fiacco E, Zuber V, Di Micco R, Gazzetta G, Valentini A, Mueller MD, Papadia A, Gentilini OD.
- Medicina (Kaunas). 2019 Jul 29;55(8). pii: E415. doi: 10.3390/medicina55080415.
- PMID: 31362334
- PubMed abstract
- Source abstract
- Editorial
- Free Full Text
-
- Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy.
- Wei M, Maurer KA, Henry NL.
- Breast J. 2019 Jul 4. doi: 10.1111/tbj.13454. [Epub ahead of print]
- PMID: 31273878
- PubMed abstract
- Source abstract
-
- How Safe Is Hormone Replacement Therapy After Risk-Reducing Salpingo-oophorectomy in Women With BRCA Mutations?
- Markman M.
- Medscape Oncology. 2019 Jun 14.
- Commentary
- Free Full Text
Original research:
Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
-
- Women's health 2019: Osteoporosis, breast cancer, contraception, and hormone therapy.
- Moreno AC, Sahni SK, Smith TL, Batur P.
- Cleve Clin J Med. 2019 Jun;86(6):400-406. doi: 10.3949/ccjm.86a.18130.
- PMID: 31204979
- PubMed abstract
-
- Long-term morbidity and health after early menopause due to oophorectomy in women at increased risk of ovarian cancer: rationale and design of the harmony study.
- Terra L, Hooning MJ, Heemskerk-Gerritsen BAM, Maas AHEM, van Leeuwen FE, HARMOny investigators.
- Maturitas. 2019 Jun;124:159-160. doi: 10.1016/j.maturitas.2019.04.136.
-
- Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
- Stanciu PI, Ind TEJ, Barton DPJ, Butler JB, Vroobel KM, Attygalle AD, Nobbenhuis MAE.
- J Ovarian Res. 2019 May 25;12(1):50. doi: 10.1186/s13048-019-0525-1.
- PMID: 31128592
- PubMed abstract
-
- Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2
- Gordhandas S, Norquist BM, Pennington KP, Yung RL, Laya MB, Swisher EM.
- Gynecol Oncol. 2019 Apr;153(1):192-200. doi: 10.1016/j.ygyno.2018.12.014. Epub 2019 Jan 17.
- PMID: 30661763
- PubMed abstract
- Source abstract
Commentary: How Safe Is Hormone Replacement Therapy After Risk-Reducing Salpingo-oophorectomy in Women With BRCA Mutations? (Medscape Oncology)
-
- Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines.
- Vermeulen RFM, Korse CM, Kenter GG, Brood-van Zanten MMA, Beurden MV.
- Climacteric. 2019 Mar 25:1-9. doi: 10.1080/13697137.2019.1582622. [Epub ahead of print]
- PMID: 30905183
- PubMed abstract
- Source abstract
-
- Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial.
- van Driel C, de Bock GH, Schroevers MJ, Mourits MJ.
- BJOG. 2019 Feb;126(3):402-411. doi: 10.1111/1471-0528.15471. Epub 2018 Oct 23.
- PMID: 30222235
- PubMed abstract
- Source abstract
Review:
Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.
- PMID: 31595976
- PubMed abstract
- Source abstract
-
- Determinants of hormone therapy uptake and decision-making after bilateral oophorectomy (BO): A narrative review.
- Siyam T, Carbon J, Ross S, Yuksel N.
- Maturitas. 2019 Feb;120:68-76. doi: 10.1016/j.maturitas.2018.11.005. Epub 2018 Nov 12.
- PMID: 30583767
- PubMed abstract
- Source abstract
-
- Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration.
- Zeydan B, Tosakulwong N, Schwarz CG, Senjem ML, Gunter JL, Reid RI, Gazzuola Rocca L, Lesnick TG, Smith CY, Bailey KR, Lowe VJ, Roberts RO, Jack CR Jr, Petersen RC, Miller VM, Mielke MM, Rocca WA, Kantarci K.
- JAMA Neurol. 2019 Jan 1;76(1):95-100. doi: 10.1001/jamaneurol.2018.3057.
- PMID: 30326011
- PubMed abstract
-
- Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.
- Teixeira N, Mourits MJ, Oosterwijk JC, Fakkert IE, Absalom AR, Bakker SJL, van der Meer P, de Bock GH.
- Fam Cancer. 2019 Jan;18(1):19-27. doi: 10.1007/s10689-018-0091-5.
- PMID: 29881922
- PubMed abstract
-
- Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
- Hall E, Finch A, Jacobson M, Rosen B, Metcalfe K, Sun P, Narod SA, Kotsopoulos J.
- Gynecol Oncol. 2019 Jan;152(1):145-150. doi: 10.1016/j.ygyno.2018.10.040. Epub 2018 Nov 7.
- PMID: 30414741
- PubMed abstract
- Source abstract
-
- Does anti-Müllerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study.
- Vermeulen RFM, van Beurden M, Gaarenstroom KN, Teunis T, Kieffer JM, Aaronson NK, Kenter GG, Korse CM.
- Climacteric. 2018 Dec;21(6):574-580. doi: 10.1080/13697137.2018.1512965. Epub 2018 Oct 8.
- PMID: 30295077
- PubMed abstract
- Source abstract
-
- Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers.
- D'Alonzo M, Piva E, Pecchio S, Liberale V, Modaffari P, Ponzone R, Biglia N.
- Clin Breast Cancer. 2018 Dec;18(6):e1361-e1366. doi: 10.1016/j.clbc.2018.07.015. Epub 2018 Jul 26.
- PMID: 30122348
- PubMed abstract
- Source abstract
-
- Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis.
- Marchetti C, De Felice F, Boccia S, Sassu C, Di Donato V, Perniola G, Palaia I, Monti M, Muzii L, Tombolini V, Benedetti Panici P.
- Crit Rev Oncol Hematol. 2018 Dec;132:111-115. doi: 10.1016/j.critrevonc.2018.09.018. Epub 2018 Oct 3.
- PMID: 30447915
- PubMed abstract
- Source abstract
-
- Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations.
- Powell CB, Alabaster A, Armstrong MA, Stoller N, Raine-Bennett T.
- Gynecol Oncol. 2018 Dec;151(3):489-493. doi: 10.1016/j.ygyno.2018.10.010. Epub 2018 Oct 10.
- PMID: 30314670
- PubMed abstract
- Source abstract
-
- No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
- Jacobson M, Bernardini M, Sobel ML, Kim RH, McCuaig J, Allen L.
- J Obstet Gynaecol Can. 2018 Nov;40(11):1497-1510. doi: 10.1016/j.jogc.2018.05.046.
- PMID: 30473125
- PubMed abstract
- Source abstract
[Article in French]:
No 366 - Prise en charge gynécologique du cancer du sein et de l'ovaire héréditaire.
- PMID: 30473126
- PubMed abstract
- Source abstract
-
- Hormone therapy and breast cancer risk after ovary removal in women with a BRCA1 mutation.
- [No author given]
- FORCE. XRAYS. 2018 Sep 7.
- Research news
- Free Full Text
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
- PMID: 29710224
- PubMed abstract
- Free Full Text
-
- Change in Inflammatory Biomarkers and Adipose Tissue in BRCA1/2+ Breast Cancer Survivors Following a Yearlong Lifestyle Modification Program.
- Sturgeon KM, Foo W, Heroux M, Schmitz K.
- Cancer Prev Res (Phila). 2018 Sep;11(9):545-550. doi: 10.1158/1940-6207.CAPR-18-0098. Epub 2018 Jun 20.
- PMID: 29925515
- PubMed abstract
- Source abstract
-
- Surgery for BRCA, TP53 and PALB2: a literature review.
- Song CV, Teo SH, Taib NA, Yip CH.
- Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018.
- PMID: 30174725
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
- Kotsopoulos J, Gronwald J, Karlan BY, Huzarski T, Tung N, Moller P, Armel S, Lynch HT, Senter L, Eisen A, Singer CF, Foulkes WD, Jacobson MR, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.
- JAMA Oncol. 2018 Aug 1;4(8):1059-1065. doi: 10.1001/jamaoncol.2018.0211.
- PMID: 29710224
- PubMed abstract
- Source abstract
Research News: Hormone therapy and breast cancer risk after ovary removal in women with a BRCA1 mutation. (FORCE, XRAYS)
Commentary, Video: Menopausal Hormone Therapy and Risk for Breast Cancer in BRCA1 Mutation Carriers. (Medscape)
-
- Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.
- Casey MJ, Salzman TA.
- Linacre Q. 2018 Aug;85(3):225-240. doi: 10.1177/0024363918788340. Epub 2018 Jul 20.
- PMID: 30275608
- PubMed abstract
- Source abstract
-
- The risk of stroke after bilateral salpingo-oophorectomy at hysterectomy for benign diseases: A nationwide cohort study.
- Lai JC, Chou YJ, Huang N, Chen HH, Wang KL, Wang CW, Shen IH, Chang HC.
- Maturitas. 2018 Aug;114:27-33. doi: 10.1016/j.maturitas.2018.05.007. Epub 2018 May 19.
- PMID: 29907243
- PubMed abstract
- Source abstract
-
- Mortality and Risk of Cancer After Prophylactic Bilateral Oophorectomy in Women With a Family History of Cancer.
- Abildgaard J, Ahlström MG, Daugaard G, Nielsen DL, Tønnes Pedersen A, Lindegaard B, Obel N.
- JNCI Cancer Spectrum. 2018 Jul 1;2(3):pky034. doi: 10.1093/jncics/pky034.
-
- Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy.
- Johansen N, Liavaag AH, Mørkrid L, Michelsen TM.
- Sex Med. 2018 Jun;6(2):143-153. doi: 10.1016/j.esxm.2018.02.002. Epub 2018 Apr 7.
- PMID: 29631858
- PubMed abstract
-
- Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy.
- Stuursma A, van Driel CMG, Wessels NJ, de Bock GH, Mourits MJE.
- Maturitas. 2018 May;111:69-76. doi: 10.1016/j.maturitas.2018.01.012. Epub 2018 Jan 13.
- PMID: 29673834
- PubMed abstract
- Source abstract
-
- Prophylactic salpingo-oophorectomy & surgical menopause for inherited risks of cancer: the need to identify biomarkers to assess the theoretical risk of premature coronary artery disease.
- Batulan Z, Maarouf N, Shrivastava V, O'Brien E.
- Womens Midlife Health. 2018 Apr 27;4:7. doi: 10.1186/s40695-018-0037-y. eCollection 2018.
- PMID: 30766717
- PubMed abstract
-
- Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers.
- Gast KC, Viscuse PV, Nowsheen S, Haddad TC, Mutter RW, Wahner Hendrickson AE, Couch FJ, Ruddy KJ.
- Curr Treat Options Cardiovasc Med. 2018 Mar 1;20(2):18. doi: 10.1007/s11936-018-0609-z.
- PMID: 29497862
- PubMed abstract
- Source abstract
-
- Commercially Available Lifestyle Modification Program Decreases Inflammatory Biomarkers in BRCA1/2+ Breast Cancer Survivors.
- Sturgeon KM, Foo W, Schmitz KH/
- Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):357-357. doi: 10.1158/1055-9965.EPI-18-0063.
-
- Bone loss in women with BRCA1 and BRCA2 mutations.
- Powell CB, Alabaster A, Stoller N, Armstrong MA, Salyer C, Hamilton I, Raine-Bennett T.
- Gynecol Oncol. 2018 Mar;148(3):535-539. doi: 10.1016/j.ygyno.2018.01.013.
- PMID: 29422346
- PubMed abstract
- Source abstract
-
- Breast tissue density change after oophorectomy in BRCA mutation carrier patients using visual and volumetric analysis.
- Lecler A, Dunant A, Delaloge S, Wehrer D, Moussa T, Caron O, Balleyguier C.
- Br J Radiol. 2018 Feb;91(1083):20170163. doi: 10.1259/bjr.20170163. Epub 2018 Jan 5.
- PMID: 29182397
- PubMed abstract
-
- Self-compassion, physical fitness and climacteric symptoms in oophorectomized BRCA1/2 mutation carriers.
- Arts-de Jong M, van Westerop LL, Hoogerbrugge N, Massuger LF, Maas AH, van Beek MH, de Hullu JA.
- Maturitas. 2018 Feb;108:13-17. doi: 10.1016/j.maturitas.2017.11.002. Epub 2017 Nov 3.
- PMID: 29290209
- PubMed abstract
- Source abstract
-
- Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy.
- Stuursma A, van Driel CMG, Wessels NJ, de Bock GH, Mourits MJE.
- Maturitas. 2018 Jan 12. pii: S0378-5122(17)30950-7. doi: 10.1016/j.maturitas.2018.01.012. [Epub ahead of print]
Press: Menopausal Symptoms May Last Over 10 Years After Risk-reducing Ovarian Surgery. (Medscape/Reuters)
-
- Surveillance report 2018 – Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (2013) NICE guideline CG164 [Internet].
- NICE Surveillance programme project team: Nolan K, Allaby M, McFarlane E, Murray A.
- London: National Institute for Health and Care Excellence (UK); 2018 Jan.
- PMID: 31909932
- PubMed abstract
- Guidelines, Book
- Free Full Text
-
- Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.
- De Felice F, Marchetti C, Boccia SM, Romito A, Sassu CM, Porpora MG, Muzii L, Tombolini V, Benedetti Panici P.
- Cancer Treat Rev. 2017 Dec;61:1-5. doi: 10.1016/j.ctrv.2017.09.005. Epub 2017 Sep 28.
- PMID: 29028552
- PubMed abstract
- Source abstract
-
- What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women.
- Hickey M, Trainer A, Braat S, Davey MA, Krejany E, Wark J.
- BMJ Open. 2017 Nov 14;7(11):e018758. doi: 10.1136/bmjopen-2017-018758.
- PMID: 29138210
- PubMed abstract
-
- Sexual Health Is Paramount in the Counseling of Women at Risk for Breast or Ovarian Cancer Undergoing Risk-Reducing Surgery.
- Rullo JE, Pruthi S.
- J Natl Compr Canc Netw. 2017 Nov 1;15(11):1297. doi: 10.6004/jnccn.2017.7016.
-
- The management of sexuality, intimacy, and menopause symptoms (SIMS) after prophylactic bilateral salpingo-oophorectomy: How to maintain sexual health in "previvors".
- Alexandre M, Black J, Whicker M, Minkin MJ, Ratner E.
- Maturitas. 2017 Nov;105:46-51. doi: 10.1016/j.maturitas.2017.06.003. Epub 2017 Jun 3.
- PMID: 28602465
- PubMed abstract
- Source abstract
-
- [Satisfaction and overall quality of life in BRCA positive women after prophylactic surgeries].
- Šašková P, Pavlišta D, Dostálek L.
- Rozhl Chir. 2017 Fall;96(8):328-333.
- PMID: 29058922
- PubMed abstract
-
- Impact of risk-reducing salpingo-oophorectomy in premenopausal women.
- Vermeulen RFM, Beurden MV, Korse CM, Kenter GG.
- Climacteric. 2017 Jun;20(3):212-221. doi: 10.1080/13697137.2017.1285879. Epub 2017 Mar 2.
- PMID: 28509627
- PubMed abstract
- Source abstract
-
- Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
- Johansen N, Liavaag AH, Iversen OE, Dørum A, Braaten T, Michelsen TM.
- Acta Obstet Gynecol Scand. 2017 May;96(5):547-555. doi: 10.1111/aogs.13120. Epub 2017 Mar 27.
- PMID: 28236297
- PubMed abstract
- Source abstract
-
- Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy.
- Tucker PE, Cohen PA.
- Int J Gynecol Cancer. 2017 May;27(4):847-852. doi: 10.1097/IGC.0000000000000943.
- PMID: 28333842
- PubMed abstract
- Source abstract
-
- Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy.
- Sturgeon KM, Dean LT, Heroux M, Kane J, Bauer T, Palmer E, Long J, Lynch S, Jacobs L, Sarwer DB, Leonard MB, Schmitz K.
- J Cancer Surviv. 2017 Apr;11(2):246-255. doi: 10.1007/s11764-016-0582-z. Epub 2016 Nov 21.
- PMID: 27873046
- PubMed abstract
- Source abstract
-
- The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review.
- Siyam T, Ross S, Campbell S, Eurich DT, Yuksel N.
- BMC Womens Health. 2017 Mar 21;17(1):22. doi: 10.1186/s12905-017-0370-6.
- PMID: 28320467
- PubMed abstract
- Review
- Free Full Text
-
- Early-onset primary peritoneal carcinoma from atypical cells after risk-reducing salpingo-oophorectomy for BRCA2 mutation carrier: a case report.
- Shimizu H, Ishikawa T, Iitsuka C, Homma M, Takimoto M, Sekizawa A.
- Int Cancer Conf J. 2017 Mar 21;6(3):104-108. doi: 10.1007/s13691-017-0287-9. eCollection 2017 Jul.
- PMID: 31149481
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
-
- [Clinical Management of HBOC in Our Hospital].
- Nomura H, Takeshima N.
- Gan To Kagaku Ryoho. 2017 Feb;44(2):116-120.
- PMID: 28223670
- PubMed abstract
- Source abstract
-
- Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer.
- Fakkert IE, van der Veer E, Abma EM, Lefrandt JD, Wolffenbuttel BH, Oosterwijk JC, Slart RH, Westrik IG, de Bock GH, Mourits MJ.
- PLoS One. 2017 Jan 6;12(1):e0169673. doi: 10.1371/journal.pone.0169673. eCollection 2017.
- PMID: 28060958
- PubMed abstract
-
- Sexuality and quality of life in women with a prior diagnosis of breast cancer after risk-reducing salpingo-oophorectomy.
- Tucker PE, Saunders C, Bulsara MK, Tan JJ, Salfinger SG, Green H, Cohen PA.
- Breast. 2016 Dec;30:26-31. doi: 10.1016/j.breast.2016.08.005. Epub 2016 Sep 2.
- PMID: 27592287
- PubMed abstract
- Source abstract
-
- Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation.
- Guidozzi F.
- Climacteric. 2016 Oct;19(5):419-22. doi: 10.1080/13697137.2016.1209396. Epub 2016 Jul 16.
- PMID: 27426853
- PubMed abstract
- Source abstract
- Editorial
- Free Full Text
-
- Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer.
- Nappi RE, Cassani C, Rossi M, Zanellini F, Spinillo A.
- Minerva Ginecol. 2016 Oct;68(5):602-12. Epub 2016 Feb 29.
- PMID: 26928421
- PubMed abstract
- Source abstract
-
- [Salpingectomy in ovarian cancer prevention: Evidence behind the hypothesis and surgical implications].
- Gómez-Pue D, Ibarrola-BuenAbad E, Lara-Núñez D, Vázquez-Alvarado AP, Pérez-Quintanilla M.
- Ginecol Obstet Mex. 2016 Sep;84(9):614-9.
- PMID: 29424983
- PubMed abstract
- Source abstract
-
- Cardiovascular risk of BRCA1/2 mutation carriers: A review.
- van Westerop LL, Arts-de Jong M, Hoogerbrugge N, de Hullu JA, Maas .
- Maturitas. 2016 Sep;91:135-9. doi: 10.1016/j.maturitas.2016.06.012. Epub 2016 Jun 22.
- PMID: 27451331
- PubMed abstract
- Source abstract
-
- Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
- Karam A.
- N Engl J Med. 2016 Jun 16;374(24):2403. doi: 10.1056/NEJMc1602861#SA1.
- PMID: 27305205
- PubMed abstract
- Comment, Letter
- Free Full Text
Review
The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
- PMID: 26840135
- PubMed abstract
- Source abstract
Comment / Letter
Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
- PMID: 27305206
- PubMed abstract
Comment / Letter
Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
- PMID: 27305204
- PubMed abstract
-
- Primary peritoneal cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy.
- Iavazzo C, Gkegkes ID, Vrachnis N.
- J Turk Ger Gynecol Assoc. 2016 Jan 12;17(2):73-6. doi: 10.5152/jtgga.2016.15223. eCollection [2016 Jun;].
- PMID: 27403072
- PubMed abstract
- Source abstract
-
- Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy.
- Johansen N, Liavaag AH, Tanbo TG, Dahl AA, Pripp AH, Michelsen TM.
- Gynecol Oncol. 2016 Jan;140(1):101-106. doi: 10.1016/j.ygyno.2015.11.016. Epub 2015 Nov 18.
- PMID: 26597462
- PubMed abstract
- Source abstract
-
- Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
- Patrono MG, Iniesta MD, Malpica A, Lu KH, Fernandez RO, Salvo G, Ramirez PT.
- Gynecol Oncol. 2015 Dec;139(3):568-572. doi: 10.1016/j.ygyno.2015.09.018. Epub 2015 Sep 25.
- PMID: 26407480
- PubMed abstract
- Source abstract
-
- Surveillance and health outcomes for BRCA mutation carriers following risk-reducing salpingo-oophorectomy (RRSO).
- Prendergast E, Green M, Zakhour M, Lester J, Li A, Walsh C, Rimel BJ, Leuchter R, Karlan B.
- Gynecologic Oncology. 2015 Oct;139(1):188. 2015 WAGO ABSTRACTS. doi: 10.1016/j.ygyno.2015.07.046.
-
- Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.
- Garcia C, Lyon L, Conell C, Littell RD, Powell CB.
- Gynecol Oncol. 2015 Sep;138(3):723-6. doi: 10.1016/j.ygyno.2015.06.020. Epub 2015 Jun 16.
- PMID: 26086567
- PubMed abstract
- Source abstract
-
- Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.
- Wu S, Weinstein SP, DeLeo MJ 3rd, Conant EF, Chen J, Domchek SM, Kontos D.
- Breast Cancer Res. 2015 May 19;17(1):67. doi: 10.1186/s13058-015-0577-0.
- PMID: 25986460
- PubMed abstract
-
- Discussion: Sex After Oophorectomy, Hysterectomy.
- Georgia Hurst, Amy Byer Shainman, Sharon Bober.
- My Gene Counsel. 2015 May 5.
- Blog post
- Free Full Text
-
- Breast MRI Fibroglandular Volume and Parenchymal Enhancement in BRCA1 and BRCA2 Mutation Carriers Before and Immediately After Risk-Reducing Salpingo-Oophorectomy.
- DeLeo MJ 3rd, Domchek SM, Kontos D, Conant E, Chen J, Weinstein S.
- AJR Am J Roentgenol. 2015 Mar;204(3):669-73. doi: 10.2214/AJR.13.12146.
- PMID: 25714301
- PubMed abstract
- Source abstract
-
- Managing symptoms and maximizing quality of life after preventive interventions for cancer risk reduction.
- Chapman JS, Jacoby V, Chen LM.
- Curr Opin Obstet Gynecol. 2015 Feb;27(1):40-4. doi: 10.1097/GCO.0000000000000146.
- PMID: 25502430
- PubMed abstract
- Source abstract
-
- Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer.
- Fakkert IE, Abma EM, Westrik IG, Lefrandt JD, Wolffenbuttel BH, Oosterwijk JC, Slart RH, van der Veer E, de Bock GH, Mourits MJ.
- Eur J Cancer. 2015 Feb;51(3):400-8. doi: 10.1016/j.ejca.2014.11.022. Epub 2014 Dec 18.
- PMID: 25532426
- PubMed abstract
- Source abstract
-
- Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention.
- Bober SL, Recklitis CJ, Bakan J, Garber JE, Patenaude AF.
- J Sex Med. 2015 Jan;12(1):189-97. doi: 10.1111/jsm.12713. Epub 2014 Oct 14.
- PMID: 25311333
- PubMed abstract
- Source abstract
Review:
Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.
- PMID: 31595976
- PubMed abstract
- Source abstract
-
- Serous tubal intraepithelial carcinoma: an incidental finding at the time of prophylactic bilateral salpingo-oophorectomy.
- Vaughan MH, Modesitt SC, Mo Y, Trowbridge ER.
- Case Rep Obstet Gynecol. 2015;2015:760429. doi: 10.1155/2015/760429. Epub 2015 Feb 23.
- PMID: 25802782
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free Full Text
-
- Proposal on Raloxifene use after prophylactic salpingo-oophorectomy in BRCA1-2: hypothesis and rationale.
- Gizzo S, Noventa M, Saccardi C, Litta P, D'Antona D, Nardelli GB.
- Eur J Cancer Prev. 2014 Nov;23(6):514-5. doi: 10.1097/CEJ.0000000000000003.
- PMID: 25254310
- PubMed abstract
- Source abstract
-
- Osteoporosis risk and management in BRCA1/2 women who undergo risk reducing salpingo-oophorectomy.
- Garcia C, Lyon L, Freeman J, Littell RD, Powell B.
- Gynecologic Oncology. 2014 Nov;135(2):384. 2014 WAGO ABSTRACTS. doi: 10.1016/j.ygyno.2014.07.014.
-
- [Hormone replacement therapy after salpingo-oophorectomy in BRCA 1/2 mutation carriers does not increase the risk of breast cancer.]
- Breda AS, Blaakær J.
- Ugeskr Laeger. 2014 Sep 15;176(38). pii: V03130186.
- PMID: 25294198
- PubMed abstract
- Source abstract
-
- Hormonal prevention of breast cancer.
- Thomin A, Friszer S, Fajac A, Daraï É, Chabbert-Buffet N.
- Ann Endocrinol (Paris). 2014 Jul;75(3):148-55. doi: 10.1016/j.ando.2014.04.012. Epub 2014 Jul 2.
- PMID: 24997772
- PubMed abstract
- Source abstract
-
- Hormone therapy in oophorectomized BRCA1/2 mutation carriers.
- Marchetti C, Iadarola R, Palaia I, di Donato V, Perniola G, Muzii L, Panici PB.
- Menopause. 2014 Jul;21(7):763-8. doi: 10.1097/GME.0000000000000126.
- PMID: 24253485
- PubMed abstract
- Source abstract
-
- Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.
- Chen Y, Bancroft E, Ashley S, Arden-Jones A, Thomas S, Shanley S, Saya S; Carrier Clinic Collaborators, Wakeling E, Eeles R.
- Fam Cancer. 2014 Jun;13(2):197-203. doi: 10.1007/s10689-013-9697-9.
- PMID: 24389956
- PubMed abstract
- Source abstract
-
- The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study.
- Segev Y, Iqbal J, Lubinski J, Gronwald J, Lynch HT, Moller P, Ghadirian P, Rosen B, Tung N, Kim-Sing C, Foulkes WD, Neuhausen SL, Senter L, Singer CF, Karlan B, Ping S, Narod SA; Hereditary Breast Cancer Study Group.
- Gynecol Oncol. 2013 Jul;130(1):127-31. doi: 10.1016/j.ygyno.2013.03.027. Epub 2013 Apr 3.
- PMID: 23562522
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
Subject: BRCA mutations and endometrial cancer
Subject: Article request
-
- Association of bilateral oophorectomy and body fatness in a representative sample of US women.
- McCarthy AM, Menke A, Visvanathan K.
- Gynecol Oncol. 2013 Jun;129(3):559-64. doi: 10.1016/j.ygyno.2013.02.016. Epub 2013 Feb 18.
- PMID: 23428461
- PubMed abstract
- Source abstract
-
- Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma.
- Lengyel E, Fleming S, McEwen KA, Montag A, Temkin SM.
- Gynecol Oncol. 2013 Apr;129(1):120-3. doi: 10.1016/j.ygyno.2012.12.006. Epub 2012 Dec 10.
- PMID: 23237768
- PubMed abstract
- Source abstract
-
- The management of menopausal symptoms in breast cancer survivors: case-based approach.
- Lammerink EA, de Bock GH, Schröder CP, Mourits MJ.
- Maturitas. 2012 Nov;73(3):265-8. doi: 10.1016/j.maturitas.2012.07.010. Epub 2012 Aug 9.
- PMID: 22883373
- PubMed abstract
- Source abstract
-
- The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause.
- Pezaro C, James P, McKinley J, Shanahan M, Young MA, Mitchell G.
- Fam Cancer. 2012 Sep;11(3):403-10. doi: 10.1007/s10689-012-9527-5.
- PMID: 22477030
- PubMed abstract
- Source abstract
-
- BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.
- Finch A, Evans G, Narod SA.
- Womens Health (Lond Engl). 2012 Sep;8(5):543-55. doi: 10.2217/whe.12.41.
- PMID: 22934728
- PubMed abstract
- Source abstract
- Review
- Free Full Text
Free text: BRCA Carriers, Prophylactic Salpingo-Oophorectomy and Menopause: Clinical Management Considerations and Recommendations (Medscape)
-
- Postoophorectomy Estrogen Use and Breast Cancer Risk.
- Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM, Visvanathan K.
- Obstet Gynecol. 2012 Jul;120(1):27-36.
- PMID: 22914389
- PubMed abstract
Comments from NSGC Discussion Forum Cancer SIG
Subject: hormonal birth control with ATM mutations?
Comment:
Post-oophorectomy estrogen use and breast cancer risk.
- PMID: 23437447
- PubMed abstract
-
- New findings presented on metastatic breast cancer and bilateral oophorectomy.
- Printz C.
- Cancer. 2012 Jun 1;118(11):2778. doi: 10.1002/cncr.27643.
- PMID: 22611011
- PubMed abstract
- Source abstract
- News
- Free Full Text
-
- Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older.
- McCarthy AM, Menke A, Ouyang P, Visvanathan K.
- Cancer Prev Res (Phila). 2012 Jun;5(6):847-54. doi: 10.1158/1940-6207.CAPR-11-0430. Epub 2012 May 3.
- PMID: 22556202
- PubMed abstract
- Source abstract
-
- Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.
- Cohen JV, Chiel L, Boghossian L, Jones M, Stopfer JE, Powers J, Rebbeck TR, Nathanson KL, Domchek SM.
- Fam Cancer. 2012 Mar;11(1):69-75. doi: 10.1007/s10689-011-9480-8.
- PMID: 21898151
- PubMed abstract
- Source abstract